These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6256790)

  • 1. Effect of delta 9-tetrahydrocannabinol on the morphine-induced hyperactivity of mice.
    Ulkü E; Ayhan IH; Tulunay FC; Uran B; Kaymakçalan S
    Psychopharmacology (Berl); 1980; 69(2):201-5. PubMed ID: 6256790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between delta 9-tetrahydrocannabinol and morphine on the motor activity of mice.
    Ayhan IH; Kaymakçalan S; Tulunay FC
    Psychopharmacology (Berl); 1979 May; 63(2):169-72. PubMed ID: 112635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.
    Tulunay FC; Ayhan IH; Sparber SB
    Psychopharmacology (Berl); 1982; 78(4):358-60. PubMed ID: 6296906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.
    Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jul; 260(1):5-13. PubMed ID: 7957626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.
    Bloom AS; Dewey WL
    Psychopharmacology (Berl); 1978 May; 57(3):243-8. PubMed ID: 97703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine.
    Pearl-Dowler L; Posa L; Lopez-Canul M; Teggin A; Gobbi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110805. PubMed ID: 37257771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Watanabe K; Yamamoto I; Yoshimura H
    Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of amphetamine and nomifensine on the development of morphine tolerance in the test of hypermotility in mice and catalepsy in rats.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(6):503-10. PubMed ID: 6687158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats.
    Magour S; Coper H; Fähndrich C
    Psychopharmacology (Berl); 1977 Jan; 51(2):141-5. PubMed ID: 402665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat.
    Hine B
    Psychopharmacology (Berl); 1985; 87(1):34-8. PubMed ID: 2997827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice.
    Bass CE; Martin BR
    Drug Alcohol Depend; 2000 Aug; 60(2):113-9. PubMed ID: 10940538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of morphine antinociception by ibogaine and noribogaine in morphine-tolerant mice.
    Sunder Sharma S; Bhargava HN
    Pharmacology; 1998 Nov; 57(5):229-32. PubMed ID: 9742287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol.
    McMillan DE; Leander JD; Dudley KH
    J Pharmacol Exp Ther; 1980 Jan; 212(1):85-90. PubMed ID: 7351628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat.
    Kandasamy R; Dawson CT; Hilgendorf TN; Morgan MM
    Behav Pharmacol; 2018 Aug; 29(5):469-472. PubMed ID: 29462111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant actions of delta9-tetrahydrocannabinol in mice.
    Evans MA; Harbison RD; Brown DJ; Forney RB
    Psychopharmacology (Berl); 1976 Nov; 50(3):245-50. PubMed ID: 826969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.